Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Civil Monetary Penalties For Human Subject Protection Sought By HHS

This article was originally published in The Gray Sheet

Executive Summary

HHS plans to submit a legislative proposal to Congress by year-end that would authorize FDA to levy civil monetary penalties for infractions of human research subject protections rules, the Clinton administration announced May 23.

You may also be interested in...



BIMO Would Step Up Inspections Of IRBs, Device Trial Sponsors In FY 2002

On-site inspections of the device research community through CDRH's Bioresearch Monitoring (BIMO) Program would increase by 30% to 325 annually, under President Bush's fiscal 2002 budget proposal.

BIMO Would Step Up Inspections Of IRBs, Device Trial Sponsors In FY 2002

On-site inspections of the device research community through CDRH's Bioresearch Monitoring (BIMO) Program would increase by 30% to 325 annually, under President Bush's fiscal 2002 budget proposal.

Device Trials Require Unique Financial Conflict Of Interest Solution

HHS should tailor its approach to disclosure of financial conflict of interest in device clinical trials vis avis pharmaceutical studies, AdvaMed (formally HIMA) Executive VP-Technology and Regulatory Affairs Jim Benson maintained.

Related Content

UsernamePublicRestriction

Register

MT013427

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel